Please login to the form below

Not currently logged in
Email:
Password:

investment

This page shows the latest investment news and features for those working in and with pharma, biotech and healthcare.

MSD taps Austria’s Themis to bolster vaccine pipeline

MSD taps Austria’s Themis to bolster vaccine pipeline

MSD is providing research funding and will also make an equity investment in Vienna-based Themis, which has already used its platform to develop a vaccine candidate called MV-CHIK for

Latest news

More from news
Approximately 8 fully matching, plus 1,654 partially matching documents found.

Latest Intelligence

  • Building Europe’s next breakthrough biotechs Building Europe’s next breakthrough biotechs

    The accelerator’s leaders say it will be the first in the Cambridge cluster to provide life science and healthcare start-ups with significant investment, which it claims could reach up ... success. In our view, corporate and institutional investors

  • Streamlining clinical trials – why better data use is key Streamlining clinical trials – why better data use is key

    Investment in patient enrolment and fulfilling compliance requirements are likely to remain staples of clinical drug trials – and for good reason.

  • The social dilemma: is it time for pharma to join the party?

    We’re concerned about the regulations and the level of investment it might take to safely contribute to the social conversation. ... That requires infrastructure and investment to ensure the conversations they have are ethical, professional and

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    LifeArc already has a stake in a broad range of translational research, from investments in small-scale academic research to major drug development alliances with pharma, but now plans a significant ... In a recent article for Forbes, she cited research

  • 25 Women Leaders in UK Healthcare (part 2) 25 Women Leaders in UK Healthcare (part 2)

    Indeed, the hospital is among the most active clinical trial centres in the UK,   attracting inward investment and addressing unmet need in patients.

More from intelligence
Approximately 3 fully matching, plus 286 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 94 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 172 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics